Phase III Clinical Study Evaluating the Safety, Pharmacokinetics, and Efficacy of JKN2301 Dry Suspension in Pediatric Patients Aged 2 to Under 12 Years With Influenza

Recruiting now · Phase 3 · Has a placebo group

Conditions studied: Respiratory Viral Infection

In brief

The goal of this phase III study is to learn if JKN2301 Dry Suspension works to treat uncomplicated influenza in Pediatric Participants aged 2 to 11 years.

Key facts

Study ID
NCT07357051
Run by
Joincare Pharmaceutical Group Industry Co., Ltd
People needed
177
Starts
2025-11-07
Expected to finish
2026-04-15
Last updated by the study team
2026-01-21

Who can join

Age: 2 and older, up to 11. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.